Aug 01 2025 This Week in Cardiology
Please note that the text below is not a full transcript and has not been copyedited. For more…
All Hype or Some Hope?
Media consumers are bombarded daily with aggressive, testimonial-driven ads for pricey supplements purported to sharpen memory, focus, and…
Combination CVD Meds Tied to Slower Cognitive Decline
Older adults taking a combination of medications to treat high blood pressure, cholesterol, and diabetes experienced slower cognitive…
Jul 25 2025 This Week in Cardiology
Please note that the text below is not a full transcript and has not been copyedited. For more…
Subclinical Primary Aldosteronism Ups MACE Risk Despite BP
Subclinical primary aldosteronism (PA) is associated with increased risks for major cardiovascular problems, even in people with normal…
Sleep Quality Next Target for CV Health
From the Dalai Lama’s claim that it is the “best meditation” to Benjamin Franklin’s insistence that it makes…
Does Romosozumab Deserve Its Black Box Warning?
Osteoporosis drug romosozumab showed no increased risk for the development of cardiovascular (CV) events compared with anabolic osteoporosis…